Toxoplasma gondii: 25 years and 25 major advances for the field

International Journal for Parasitology

Volumn 39, Issue 8, 2009, Pages 935-946

  Boothroyd, John C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell biology; Diagnosis; Genetics; Molecular biology; Population biology; Toxoplasma gondii; Treatment; Vaccines

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 2; LIVE VACCINE; PROTEIN; ANTIINFECTIVE AGENT; PROTOZOAL PROTEIN; PROTOZOAL VACCINE;

BIOLOGICAL ANALYSIS; CYTOLOGY; GENETICS; POPULATION ECOLOGY; PROTOZOAN; RESEARCH WORK; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASEXUAL REPRODUCTION; BACTERIAL STRAIN; BRADYZOITE; CELL INVASION; CELL MOTILITY; CHROMOSOME; CLINICAL TRIAL; CLONAL VARIATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG TARGETING; GENE MAPPING; GENOME; HAPLOTYPE; HOST CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NONHUMAN; OOCYST; PARASITE; PHENOTYPE; PLASTID; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; TACHYZOITE; TOXOPLASMA; TOXOPLASMA GONDII; TOXOPLASMIC ENCEPHALITIS; TOXOPLASMOSIS; VACCINATION; ANIMAL; CAT; CELL ORGANELLE; CHROMOSOMAL MAPPING; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIFE CYCLE STAGE; MOUSE; PARASITOLOGY; PHYLOGENY; PHYSIOLOGY; PREGNANCY; RESEARCH; TRENDS; ULTRASTRUCTURE;

ANIMALS; ANTI-INFECTIVE AGENTS; CATS; CHROMOSOME MAPPING; FEMALE; GENOME, PROTOZOAN; HOST-PARASITE INTERACTIONS; HUMANS; LIFE CYCLE STAGES; MICE; ORGANELLES; PHYLOGENY; POLYMERASE CHAIN REACTION; PREGNANCY; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RESEARCH; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 67349214385     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2009.02.003     Document Type: Review

References (151)

1. Alexander D.L., Mital J., Ward G.E., Bradley P., and Boothroyd J.C. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog. 1 (2005) e17
2. Aliberti J., Valenzuela J.G., Carruthers V.B., Hieny S., Andersen J., Charest H., Reise Sousa C., Fairlamb A., Ribeiro J.M., and Sher A. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4 (2003) 485-490
3. Aosai F., Rodriguez Pena M.S., Mun H.S., Fang H., Mitsunaga T., Norose K., Kang H.K., Bae Y.S., and Yano A. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones 11 (2006) 13-22
4. Beckers C.J., Dubremetz J.F., Mercereau-Puijalon O., and Joiner K.A. The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J. Cell Biol. 127 (1994) 947-961
5. Berdoy M., Webster J.P., and Macdonald D.W. Fatal attraction in rats infected with Toxoplasma gondii. Proc. R. Soc. Lond. B Biol. Sci. 267 (2000) 1591-1594
6. Blader I.J., Manger I.D., and Boothroyd J.C. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J. Biol. Chem. 276 (2001) 24223-24231
7. Blanchard N., Gonzalez F., Schaeffer M., Joncker N.T., Cheng T., Shastri A.J., Robey E.A., and Shastri N. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat. Immunol. 9 (2008) 937-944
8. Bohne W., Heesemann J., and Gross U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 62 (1994) 1761-1767
9. Borst P., Overdulve J.P., Weijers P.J., Fase-Fowler F., and Van den Berg M. DNA circles with cruciforms from Isospora (Toxoplasma) gondii. Biochim. Biophys. Acta 781 (1984) 100-111
10. Bourguin I., Moser M., Buzoni-Gatel D., Tielemans F., Bout D., Urbain J., and Leo O. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66 (1998) 4867-4874
11. Bradley P.J., Ward C., Cheng S.J., Alexander D.L., Coller S., Coombs G.H., Dunn J.D., Ferguson D.J., Sanderson S.J., Wastling J.M., and Boothroyd J.C. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J. Biol. Chem. 280 (2005) 34245-34258
12. Brown C.R., David C.S., Khare S.J., and McLeod R. Effects of human class I transgenes on Toxoplasma gondii cyst formation. J. Immunol. 152 (1994) 4537-4541
13. Brown C.R., Hunter C.A., Estes R.G., Beckmann E., Forman J., David C., Remington J.S., and McLeod R. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85 (1995) 419-428
14. Burg J.L., Perelman D., Kasper L.H., Ware P.L., and Boothroyd J.C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141 (1988) 3584-3591
15. Butcher B.A., Kim L., Johnson P.F., and Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J. Immunol. 167 (2001) 2193-2201
16. Buxton D., Thomson K., Maley S., Wright S., and Bos H.J. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 129 (1991) 89-93
17. Caamano J., Alexander J., Craig L., Bravo R., and Hunter C.A. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163 (1999) 4453-4461
18. Camps M., Arrizabalaga G., and Boothroyd J. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43 (2002) 1309-1318
19. Carruthers V.B., Sherman G.D., and Sibley L.D. The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases. J. Biol. Chem. 275 (2000) 14346-14353
20. Cesbron-Delauw M.F., Guy B., Torpier G., Pierce R.J., Lenzen G., Cesbron J.Y., Charif H., Lepage P., Darcy F., Lecocq J.P., et al. Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 86 (1989) 7537-7541
21. Charest H., Sedegah M., Yap G.S., Gazzinelli R.T., Caspar P., Hoffman S.L., and Sher A. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria. J. Immunol. 165 (2000) 2084-2092
22. Chaussabel D., Semnani R.T., McDowell M.A., Sacks D., Sher A., and Nutman T.B. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102 (2003) 672-681
23. Coppens I., Dunn J.D., Romano J.D., Pypaert M., Zhang H., Boothroyd J.C., and Joiner K.A. Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 125 (2006) 261-274
24. Coppin A., Dzierszinski F., Legrand S., Mortuaire M., Ferguson D., and Tomavo S. Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii. Biochimie 85 (2003) 353-361
25. Crawford M.J., Thomsen-Zieger N., Ray M., Schachtner J., Roos D.S., and Seeber F. Toxoplasma gondii scavenges host-derived lipoic acid despite its de novo synthesis in the apicoplast. EMBO J. 25 (2006) 3214-3222
26. Darde M.L., Bouteille B., and Pestre-Alexandre M. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol. 78 (1992) 786-794
27. Denkers E.Y., Gazzinelli R.T., Martin D., and Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 178 (1993) 1465-1472
28. Derouin F., Thulliez P., and Romand S. Schizophrenia and serological methods for diagnosis of toxoplasmosis. Clin. Infect. Dis. 34 (2002) 127-129
29. Destounis, N., 1966. The relationship between schizophrenia and toxoplasmosis. A critical study. Del. Med. J. 38, 349-351(passim).
30. Donald R.G., and Roos D.S. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc. Natl. Acad. Sci. USA 90 (1993) 11703-11707
31. Dubremetz J.F., Achbarou A., Bermudes D., and Joiner K.A. Kinetics and pattern of organelle exocytosis during Toxoplasma gondii/host-cell interaction. Parasitol. Res. 79 (1993) 402-408
32. Dzierszinski F., Mortuaire M., Dendouga N., Popescu O., and Tomavo S. Differential expression of two plant-like enolases with distinct enzymatic and antigenic properties during stage conversion of the protozoan parasite Toxoplasma gondii. J. Mol. Biol. 309 (2001) 1017-1027
33. El Hajj H., Demey E., Poncet J., Lebrun M., Wu B., Galeotti N., Fourmaux M.N., Mercereau-Puijalon O., Vial H., Labesse G., and Dubremetz J.F. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 6 (2006) 5773-5784
34. El Hajj H., Lebrun M., Arold S.T., Vial H., Labesse G., and Dubremetz J.F. ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii. PLoS Pathog. 3 (2007) e14
35. Fichera M.E., and Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature 390 (1997) 407-409
36. Fischer H.G., Stachelhaus S., Sahm M., Meyer H.E., and Reichmann G. GRA7, an excretory 29 kDa Toxoplasma gondii dense granule antigen released by infected host cells. Mol. Biochem. Parasitol. 91 (1998) 251-262
37. Flegr J., Havlicek J., Kodym P., Maly M., and Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2 (2002) 11
38. Fouts A.E., and Boothroyd J.C. Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection. Infect. Immun. 75 (2007) 634-642
39. Fox B.A., and Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 415 (2002) 926-929
40. Frickel E.M., Sahoo N., Hopp J., Gubbels M.J., Craver M.P., Knoll L.J., Ploegh H.L., and Grotenbreg G.M. Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J. Infect. Dis. 198 (2008) 1625-1633
41. Fuentes I., Rubio J.M., Ramirez C., and Alvar J. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J. Clin. Microbiol. 39 (2001) 1566-1570
42. Gajria B., Bahl A., Brestelli J., Dommer J., Fischer S., Gao X., Heiges M., Iodice J., Kissinger J.C., Mackey A.J., Pinney D.F., Roos D.S., Stoeckert Jr. C.J., Wang H., and Brunk B.P. ToxoDB: an integrated Toxoplasma gondii database resource. Nucleic Acids Res. 36 (2008) D553-D556
43. Gardner M.J., Feagin J.E., Moore D.J., Spencer D.F., Gray M.W., Williamson D.H., and Wilson R.J. Organisation and expression of small subunit ribosomal RNA genes encoded by a 35-kilobase circular DNA in Plasmodium falciparum. Mol. Biochem. Parasitol. 48 (1991) 77-88
44. Gardner M.J., Williamson D.H., and Wilson R.J. A circular DNA in malaria parasites encodes an RNA polymerase like that of prokaryotes and chloroplasts. Mol. Biochem. Parasitol. 44 (1991) 115-123
45. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., and Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153 (1994) 2533-2543
46. Gilbert L.A., Ravindran S., Turetzky J.M., Boothroyd J.C., and Bradley P.J. Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot. Cell 6 (2007) 73-83
47. Goebel S., Luder C.G., and Gross U. Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin D-induced apoptosis. Med. Microbiol. Immunol. (Berl.) 187 (1999) 221-226
48. Goebel S., Gross U., and Luder C.G. Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J. Cell Sci. 114 (2001) 3495-3505
49. Grigg M.E., Ganatra J., Boothroyd J.C., and Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184 (2001) 633-639
50. Grover C.M., Thulliez P., Remington J.S., and Boothroyd J.C. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J. Clin. Microbiol. 28 (1990) 2297-2301
51. Hakansson S., Charron A.J., and Sibley L.D. Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J. 20 (2001) 3132-3144
52. Haque S., Dumon H., Haque A., and Kasper L.H. Alteration of intracellular calcium flux and impairment of nuclear factor-AT translocation in T cells during acute Toxoplasma gondii infection in mice. J. Immunol. 161 (1998) 6812-6818
53. Hay J., Aitken P.P., Hair D.M., Hutchison W.M., and Graham D.I. The effect of congenital Toxoplasma infection on mouse activity and relative preference for exposed areas over a series of trials. Ann. Trop. Med. Parasitol. 78 (1984) 611-618
54. Hinze-Selch, D., Daubener, W., Eggert, L., Erdag, S., Stoltenberg, R., Wilms, S., 2007. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull.
55. Hisaeda H., Sakai T., Ishikawa H., Maekawa Y., Yasutomo K., Good R.A., and Himeno K. Heat shock protein 65 induced by gammadelta T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii. J. Immunol. 159 (1997) 2375-2381
56. Hitziger N., Dellacasa I., Albiger B., and Barragan A. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol. 7 (2005) 837-848
57. Howe D.K., and Sibley L.D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172 (1995) 1561-1566
58. Huynh M.H., Rabenau K.E., Harper J.M., Beatty W.L., Sibley L.D., and Carruthers V.B. Rapid invasion of host cells by Toxoplasma requires secretion of the MIC2-M2AP adhesive protein complex. EMBO J. 22 (2003) 2082-2090
59. Huynh M.H., and Carruthers V.B. Toxoplasma MIC2 is a major determinant of invasion and virulence. PLoS Pathog. 2 (2006) e84
60. Jewett T.J., and Sibley L.D. Aldolase forms a bridge between cell surface adhesins and the actin cytoskeleton in apicomplexan parasites. Mol. Cell 11 (2003) 885-894
61. Jung C., Lee C.Y., and Grigg M.E. The SRS superfamily of Toxoplasma surface proteins. Int. J. Parasitol. 34 (2004) 285-296
62. Kaeser H.E., Kocher R., and Dietrich R. Toxoplasmosis of the nervous system and multiple sclerosis. Lancet 2 (1977) 1029
63. Kasper L.H., Crabb J.H., and Pfefferkorn E.R. Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. J. Immunol. 130 (1983) 2407-2412
64. Kasper L.H. Identification of stage-specific antigens of Toxoplasma gondii. Infect. Immun. 57 (1989) 668-672
65. Khan A., Su C., German M., Storch G.A., Clifford D.B., and Sibley L.D. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J. Clin. Microbiol. 43 (2005) 5881-5887
66. Khan A., Taylor S., Su C., Mackey A.J., Boyle J., Cole R., Glover D., Tang K., Paulsen I.T., Berriman M., Boothroyd J.C., Pfefferkorn E.R., Dubey J.P., Ajioka J.W., Roos D.S., Wootton J.C., and Sibley L.D. Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii. Nucleic Acids Res. 33 (2005) 2980-2992
67. Khan A., Bohme U., Kelly K.A., Adlem E., Brooks K., Simmonds M., Mungall K., Quail M.A., Arrowsmith C., Chillingworth T., Churcher C., Harris D., Collins M., Fosker N., Fraser A., Hance Z., Jagels K., Moule S., Murphy L., O'Neil S., Rajandream M.A., Saunders D., Seeger K., Whitehead S., Mayr T., Xuan X., Watanabe J., Suzuki Y., Wakaguri H., Sugano S., Sugimoto C., Paulsen I., Mackey A.J., Roos D.S., Hall N., Berriman M., Barrell B., Sibley L.D., and Ajioka J.W. Common inheritance of chromosome Ia associated with clonal expansion of Toxoplasma gondii. Genome Res. 16 (2006) 1119-1125
68. Khan I.A., Matsuura T., and Kasper L.H. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62 (1994) 1639-1642
69. Kim J.M., Oh Y.K., Kim Y.J., Cho S.J., Ahn M.H., and Cho Y.J. Nuclear factor-kappa B plays a major role in the regulation of chemokine expression of HeLa cells in response to Toxoplasma gondii infection. Parasitol. Res. 87 (2001) 758-763
70. Kim K., and Boothroyd J.C. Stable transformation of the opportunistic pathogen Toxoplasma using chloramphenicol selection. Clin. Res. 41 (1993) 209A
71. Kim K., Soldati D., and Boothroyd J.C. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science 262 (1993) 911-914
72. Kim S.K., and Boothroyd J.C. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J. Immunol. 174 (2005) 8038-8048
73. Kim S.K., Fouts A.E., and Boothroyd J.C. Toxoplasma gondii dysregulates IFN-{gamma}-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J. Immunol. 178 (2007) 5154-5165
74. Kim S.K., Karasov A., and Boothroyd J.C. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect. Immun. 75 (2007) 1626-1634
75. Kissinger J.C., Gajria B., Li L., Paulsen I.T., and Roos D.S. ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res. 31 (2003) 234-236
76. Knight B.C., Kissane S., Falciani F., Salmon M., Stanford M.R., and Wallace G.R. Expression analysis of immune response genes of Muller cells infected with Toxoplasma gondii. J. Neuroimmunol. 179 (2006) 126-131
77. Kohler S., Delwiche C.F., Denny P.W., Tilney L.G., Webster P., Wilson R.J., Palmer J.D., and Roos D.S. A plastid of probable green algal origin in Apicomplexan parasites [see comments]. Science 275 (1997) 1485-1489
78. Kong J.T., Grigg M.E., Uyetake L., Parmley S., and Boothroyd J.C. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J. Infect. Dis. 187 (2003) 1484-1495
79. Kovacs J.A. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Lancet 340 (1992) 637-638
80. Kupfer M.C., Zee C.S., Colletti P.M., Boswell W.D., and Rhodes R. MRI evaluation of AIDS-related encephalopathy: toxoplasmosis vs. lymphoma. Magn. Reson. Imaging 8 (1990) 51-57
81. Laissy J.P., Soyer P., Tebboune J., Gay-Depassier P., Casalino E., Lariven S., Sibert A., and Menu Y. Contrast-enhanced fast MRI in differentiating brain toxoplasmosis and lymphoma in AIDS patients. J. Comput. Assist. Tomogr. 18 (1994) 714-718
82. Lebrun M., Michelin A., El Hajj H., Poncet J., Bradley P.J., Vial H., and Dubremetz J.F. The rhoptry neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion. Cell. Microbiol. 7 (2005) 1823-1833
83. Lecordier L., Mercier C., Torpier G., Tourvieille B., Darcy F., Liu J.L., Maes P., Tartar A., Capron A., and Cesbron-Delauw M.F. Molecular structure of a Toxoplasma gondii dense granule antigen (GRA 5) associated with the parasitophorous vacuole membrane. Mol. Biochem. Parasitol. 59 (1993) 143-153
84. Lecordier L., Moleon-Borodowsky I., Dubremetz J.F., Tourvieille B., Mercier C., Deslee D., Capron A., and Cesbron-Delauw M.F. Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole. Mol. Biochem. Parasitol. 70 (1995) 85-94
85. Lehmann T., Marcet P.L., Graham D.H., Dahl E.R., and Dubey J.P. Globalization and the population structure of Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 103 (2006) 11423-11428
86. Lekutis C., Ferguson D.J., and Boothroyd J.C. Toxoplasma gondii: identification of a developmentally regulated family of genes related to SAG2. Exp. Parasitol. 96 (2000) 89-96
87. Liesenfeld O., Kosek J.C., and Suzuki Y. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. Infect. Immun. 65 (1997) 4682-4689
88. Mack D.G., Johnson J.J., Roberts F., Roberts C.W., Estes R.G., David C., Grumet F.C., and McLeod R. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 29 (1999) 1351-1358
89. Marshall V.M., Peterson M.G., Lew A.M., and Kemp D.J. Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi. Mol. Biochem. Parasitol. 37 (1989) 281-283
90. Matrajt M., Donald R.G., Singh U., and Roos D.S. Identification and characterization of differentiation mutants in the protozoan parasite Toxoplasma gondii. Mol. Microbiol. 44 (2002) 735-747
91. McCabe R.E., Luft B.J., and Remington J.S. Effect of murine interferon gamma on murine toxoplasmosis. J. Infect. Dis. 150 (1984) 961-962
92. McFadden D.C., Tomavo S., Berry E.A., and Boothroyd J.C. Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance [In Process Citation]. Mol. Biochem. Parasitol. 108 (2000) 1-12
93. McLeod R., Frenkel J.K., Estes R.G., Mack D.G., Eisenhauer P.B., and Gibori G. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge. J. Immunol. 140 (1988) 1632-1637
94. Meenken C., Rothova A., de Waal L.P., van der Horst A.R., Mesman B.J., and Kijlstra A. HLA typing in congenital toxoplasmosis. Br. J. Ophthalmol. 79 (1995) 494-497
95. Meissner M., Schluter D., and Soldati D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science 298 (2002) 837-840
96. Mercier C., Lecordier L., Darcy F., Deslee D., Murray A., Tourvieille B., Maes P., Capron A., and Cesbron-Delauw M.F. Molecular characterization of a dense granule antigen (Gra 2) associated with the network of the parasitophorous vacuole in Toxoplasma gondii. Mol. Biochem. Parasitol. 58 (1993) 71-82
97. Mercier C., Cesbron-Delauw M.F., and Sibley L.D. The amphipathic alpha helices of the Toxoplasma protein GRA2 mediate post-secretory membrane association. J. Cell Sci. 111 (1998) 2171-2180
98. Mercier C., Howe D.K., Mordue D., Lingnau M., and Sibley L.D. Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice. Infect. Immun. 66 (1998) 4176-4182
99. Mevelec M.N., Chardes T., Mercereau-Puijalon O., Bourguin I., Achbarou A., Dubremetz J.F., and Bout D. Molecular cloning of GRA4, a Toxoplasma gondii dense granule protein, recognized by mucosal IgA antibodies. Mol. Biochem. Parasitol. 56 (1992) 227-238
100. Miller M.A., Grigg M.E., Kreuder C., James E.R., Melli A.C., Crosbie P.R., Jessup D.A., Boothroyd J.C., Brownstein D., and Conrad P.A. An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a cause of mortality. Int. J. Parasitol. 34 (2004) 275-284
101. Mineo J.R., McLeod R., Mack D., Smith J., Khan I.A., Ely K.H., and Kasper L.H. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J. Immunol. 150 (1993) 3951-3964
102. Minns L.A., Menard L.C., Foureau D.M., Darche S., Ronet C., Mielcarz D.W., Buzoni-Gatel D., and Kasper L.H. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J. Immunol. 176 (2006) 7589-7597
103. Mun H.S., Aosai F., Norose K., Chen M., Piao L.X., Takeuchi O., Akira S., Ishikura H., and Yano A. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. 15 (2003) 1081-1087
104. Nagel S.D., and Boothroyd J.C. The major surface antigen, P30, of Toxoplasma gondii is anchored by a glycolipid. J. Biol. Chem. 264 (1989) 5569-5574
105. Nash P.B., Purner M.B., Leon R.P., Clarke P., Duke R.C., and Curiel T.J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160 (1998) 1824-1830
106. Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158 (1983) 670-689
107. Neudeck A., Stachelhaus S., Nischik N., Striepen B., Reichmann G., and Fischer H.G. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect. 4 (2002) 581-590
108. Nichols B.A., Chiappino M.L., and O'Connor G.R. Secretion from the rhoptries of Toxoplasma gondii during host-cell invasion. J. Ultrastruct. Res. 83 (1983) 85-98
109. Nishikawa Y., Makala L., Otsuka H., Mikami T., and Nagasawa H. Mechanisms of apoptosis in murine fibroblasts by two intracellular protozoan parasites, Toxoplasma gondii and Neospora caninum. Parasite Immunol. 24 (2002) 347-354
110. Omata Y., Sethi K.K., and Brandis H. Analysis of the roles of immune interferon (IFN-gamma) and colony-stimulating factor(s) in the induction of macrophage anti-Toxoplasma activity. Immunobiology 166 (1984) 146-156
111. Payne T.M., Molestina R.E., and Sinai A.P. Inhibition of caspase activation and a requirement for NF-kappaB function in the Toxoplasma gondii-mediated blockade of host apoptosis. J. Cell Sci. 116 (2003) 4345-4358
112. Pepper M., Dzierszinski F., Crawford A., Hunter C.A., and Roos D. Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect. Immun. 72 (2004) 7240-7246
113. Peyron F., Lobry J.R., Musset K., Ferrandiz J., Gomez-Marin J.E., Petersen E., Meroni V., Rausher B., Mercier C., Picot S., and Cesbron-Delauw M.F. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 8 (2006) 2333-2340
114. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81 (1984) 908-912
115. Pfefferkorn E.R., Nothnagel R.F., and Borotz S.E. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant. Antimicrob. Agents Chemother. 36 (1992) 1091-1096
116. Prince J.B., Auer K.L., Huskinson J., Parmley S.F., Araujo F.G., and Remington J.S. Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii. Mol. Biochem. Parasitol. 43 (1990) 97-106
117. Rachinel N., Buzoni-Gatel D., Dutta C., Mennechet F.J., Luangsay S., Minns L.A., Grigg M.E., Tomavo S., Boothroyd J.C., and Kasper L.H. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J. Immunol. 173 (2004) 2725-2735
118. Roberts A., Hedman K., Luyasu V., Zufferey J., Bessieres M.H., Blatz R.M., Candolfi E., Decoster A., Enders G., Gross U., Guy E., Hayde M., Ho-Yen D., Johnson J., Lecolier B., Naessens A., Pelloux H., Thulliez P., and Petersen E. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 467-474
119. Saeij J.P., Boyle J.P., and Boothroyd J.C. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 21 (2005) 476-481
120. Saeij J.P., Boyle J.P., Grigg M.E., Arrizabalaga G., and Boothroyd J.C. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect. Immun. 73 (2005) 695-702
121. Saeij J.P., Boyle J.P., Coller S., Taylor S., Sibley L.D., Brooke-Powell E.T., Ajioka J.W., and Boothroyd J.C. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314 (2006) 1780-1783
122. Saeij J.P., Coller S., Boyle J.P., Jerome M.E., White M.W., and Boothroyd J.C. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445 (2007) 324-327
123. Saeij J.P., Arrizabalaga G., and Boothroyd J.C. A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence. Infect. Immun. 76 (2008) 2402-2410
124. Savva D., Morris J.C., Johnson J.D., and Holliman R.E. Polymerase chain reaction for detection of Toxoplasma gondii. J. Med. Microbiol. 32 (1990) 25-31
125. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., and Sher A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168 (2002) 5997-6001
126. Seeber F., Aliverti A., and Zanetti G. The plant-type ferredoxin-NADP+ reductase/ferredoxin redox system as a possible drug target against apicomplexan human parasites. Curr. Pharm. Des. 11 (2005) 3159-3172
127. Seguin R., and Kasper L.H. Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii. J. Infect. Dis. 179 (1999) 467-474
128. Shirafuji H., Xuan X., Kimata I., Takashima Y., Fukumoto S., Otsuka H., Nagasawa H., and Suzuki H. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects. J. Parasitol. 91 (2005) 476-479
129. Sibley L.D., and Boothroyd J.C. Construction of a molecular karyotype for Toxoplasma gondii. Mol. Biochem. Parasitol. 51 (1992) 291-300
130. Sibley L.D., and Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359 (1992) 82-85
131. Sibley L.D., LeBlanc A.J., Pfefferkorn E.R., and Boothroyd J.C. Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii. Genetics 132 (1992) 1003-1015
132. Sinai A.P., and Joiner K.A. The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. J. Cell Biol. 154 (2001) 95-108
133. Singh U., Brewer J.L., and Boothroyd J.C. Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction. Mol. Microbiol. 44 (2002) 721-733
134. Soete M., Fortier B., Camus D., and Dubremetz J.F. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp. Parasitol. 76 (1993) 259-264
135. Sousa C.R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., and Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [see comments]. J. Exp. Med. 186 (1997) 1819-1829
136. Srivastava I.K., Morrisey J.M., Darrouzet E., Daldal F., and Vaidya A.B. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol. Microbiol. 33 (1999) 704-711
137. Su C., Evans D., Cole R.H., Kissinger J.C., Ajioka J.W., and Sibley L.D. Recent expansion of Toxoplasma through enhanced oral transmission. Science 299 (2003) 414-416
138. Suzuki Y., Joh K., Orellana M.A., Conley F.K., and Remington J.S. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74 (1991) 732-739
139. Taylor S., Barragan A., Su C., Fux B., Fentress S.J., Tang K., Beatty W.L., Hajj H.E., Jerome M., Behnke M.S., White M., Wootton J.C., and Sibley L.D. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314 (2006) 1776-1780
140. Thomsen-Zieger N., Schachtner J., and Seeber F. Apicomplexan parasites contain a single lipoic acid synthase located in the plastid. FEBS Lett. 547 (2003) 80-86
141. Tomavo S., Schwarz R.T., and Dubremetz J.F. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Mol. Cell. Biol. 9 (1989) 4576-4580
142. Tomavo S., Fortier B., Soete M., Ansel C., Camus D., and Dubremetz J.F. Characterization of bradyzoite-specific antigens of Toxoplasma gondii. Infect. Immun. 59 (1991) 3750-3753
143. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., and Sapolsky R.M. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. USA 104 (2007) 6442-6447
144. Waldeland H., Pfefferkorn E.R., and Frenkel J.K. Temperature-sensitive mutants of Toxoplasma gondii: pathogenicity and persistence in mice. J. Parasitol. 69 (1983) 171-175
145. Waller R.F., Keeling P.J., Donald R.G., Striepen B., Handman E., Lang-Unnasch N., Cowman A.F., Besra G.S., Roos D.S., and McFadden G.I. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 95 (1998) 12352-12357
146. Wan K.L., Carruthers V.B., Sibley L.D., and Ajioka J.W. Molecular characterisation of an expressed sequence tag locus of Toxoplasma gondii encoding the micronemal protein MIC2. Mol. Biochem. Parasitol. 84 (1997) 203-214
147. Ware P.L., and Kasper L.H. Strain-specific antigens of Toxoplasma gondii. Infect. Immun. 55 (1987) 778-783
148. Webster J.P., Brunton C.F., and MacDonald D.W. Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology 109 (1994) 37-43
149. Yang S., and Parmley S.F. A bradyzoite stage-specifically expressed gene of Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase. Mol. Biochem. Parasitol. 73 (1995) 291-294
150. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., Hieny S., Sutterwala F.S., Flavell R.A., Ghosh S., and Sher A. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308 (2005) 1626-1629
151. Zangerle R., and Allerberger F. Effect of prophylaxis against Pneumocystis carinii on Toxoplasma encephalitis [letter; comment]. Lancet 337 (1991) 1232